WS #5781
The dominant signal in this window is the escalating Iran-Israel conflict, with reports of hostile drones launched inside Tehran and intercepted by Iranian air defenses, alongside a Mossad attribution. This is corroborated by multiple sources (Bluesky, NPR, Alpaca) and is driving oil prices sharply higher (WTI +3.6%, Brent +3.5%). The geopolitical risk is further amplified by reports that European airlines are slashing thousands of flights due to jet fuel supply cuts from the Iran war, and the UK is hosting talks on a Strait of Hormuz mission. Separately, Intel reported a massive Q1 earnings beat (EPS $0.29 vs $0.01 estimate, sales $13.577B vs $12.424B), sending shares higher in after-hours. The FDA approved the first gene therapy for genetic hearing loss, a milestone for biotech. On the macro front, Fed's Bowman cautioned Wall Street CEOs against capital gripes, and JPMorgan raised its S&P 500 year-end target to 7,600 on AI earnings and easing tensions. Housing data showed PulteGroup hit by the slump, and the average vehicle age hit 12.8 years, boosting tool demand for Snap-On. The Iran conflict escalation is the highest-significance development, with broad market implications for energy, airlines, and defense.
Key developments
- Hostile drones intercepted in Tehran; Mossad suspected; oil surges 3.5%+
- Intel Q1 EPS beats by 2800%, sales beat; shares rally after-hours
- European airlines slash thousands of flights as Iran war cuts jet fuel supplies
- FDA approves first gene therapy for genetic hearing loss (Otarmeni)
- Fed's Bowman cautions Wall Street CEOs against capital gripes
- JPMorgan raises S&P 500 year-end target to 7,600 on AI earnings and easing tensions
- PulteGroup reports mixed Q1 results; housing slump weighs
- Average vehicle age hits 12.8 years; Snap-On sees tool demand boost